Novo Nordisk and Gilead team up to test fatty liver disease treatment

82

Novo Nordisk and Gilead Sciences will join forces on a clinical trial combining drugs from the two pharmaceutical firms to treat a progressive fatty liver disease known as NASH.

http://feeds.reuters.com/~r/reuters/healthNews/~3/Fu5BKoJqTvo/novo-nordisk-and-gilead-team-up-to-test-fatty-liver-disease-treatment-idUSKCN1RO0Y3